In a regulatory filing, the company said "its step-down wholly owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has received tentative approval for triamcinolone acetonide ointment USP, 0.05 percent from the United States Food Drug Administration (USFDA)".from Moneycontrol Business News https://ift.tt/2U33iX9
No comments:
Post a Comment